BRIEF-Biosyent signs distribution agreement for new cardiovascular products

Wed May 25, 2016 1:06pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 25 (Reuters) - Biosyent Inc:

* Biosyent signs exclusive distribution agreement for two new cardiovascular products

* Intends to submit dossier seeking marketing approval of products to Health Canada in 2016

* Forecasts that the new products will add approximately CAD $20 million to overall revenue of company when they reach "peak sales" Source text for Eikon: Further company coverage: